Synthesis and in Vitro Anti-Proliferative Activity of Racemic Trifluoro-Casodex® (Bicalutamide)

Authors: Sani, M.; Viani, F.; Binda, M.; Zaffaroni, N.; Zanda, M.

Source: Letters in Organic Chemistry, Volume 2, Number 5, August 2005 , pp. 447-449(3)

Publisher: Bentham Science Publishers

Buy & download fulltext article:

OR

Price: $63.10 plus tax (Refund Policy)

Abstract:

The trifluoro analogue 1 of Casodex® was synthesized in racemic form, according to a strategy based on the use of trifluoropyruvate as a key starting material. This compound showed significant in vitro antiproliferative activity on the human prostate cancer cell line LNCaP.

Keywords: anti-androgen; chromatography; nucleophilic reagents; prostate cancer; trifluoro-casodex analogue

Document Type: Review Article

DOI: http://dx.doi.org/10.2174/1570178054405850

Affiliations: Dipartimento di Chimica, Materiali ed Ingegneria Chimica “G. Natta” del Politecnico di Milano and C.N.R .- Istituto di Chimica del Riconoscimento Molecolare, Sezione “A. Quilico”, via Mancinelli 7, I-20131 Milano, Italy.

Publication date: August 1, 2005

More about this publication?
  • Letters in Organic Chemistry publishes original letters on all areas of organic chemistry including synthesis, bioorganic, medicinal, natural products, organometallic, supramolecular, molecular recognition and physical organic chemistry. The emphasis is placed on publishing quality papers very rapidly. Letters are processed rapidly and take full advantage of the Internet technology both for the submission and the review of the manuscripts.
    The journal is essential reading for all organic chemists both in academia and industry.
Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page